... Log in

Clinics

Meet your clinician face to face

What your first visit costs

Your first appointment, step by step

Overview

London locations
Illustration of the ClariDay clinic at 10 Harley Street, London
Flagship

Our flagship consultation clinic in Marylebone

A calm, private setting near Smithfield

UK-licensed, clinician prescribed

Next-day weekday delivery

Cancel any time, no consultation fee

Online weight loss treatments

Compare weight loss treatments

Four licensed options, two pens and two tablets. One clinician decision, made with your history rather than a headline.

From £120 a month

Two weight loss injection pens and two daily tablets on a cream surface

The options

Pick the way it fits your week

Mounjaro weight loss injection pens lined up

Weekly pen

Most weight lost

Mounjaro

Tirzepatide · Once a week, same day

20.9%

average weight lost
SURMOUNT-1, 72 weeks

From £195 a month

Wegovy weight loss injection pens lined up

Weekly pen

Wegovy

Semaglutide · Once a week, same day

14.9%

average weight lost
STEP 1, 68 weeks

From £139 a month

Wegovy tablets packs lined up

Daily tablet

No injections

Wegovy tablets

Oral semaglutide · Once a day, before food

16.6%

average weight lost
OASIS 4, 64 weeks

From £125 a month

Foundayo orforglipron tablet packs lined up

Daily tablet

No injections

Lowest price

Foundayo

Orforglipron · Once a day, any time

12.4%

average weight lost
ATTAIN-1, 72 week

From £120 a month

Side by side

Everything that actually differs

↔ Swipe the table sideways

 MounjaroWeekly penWegovyWeekly penWegovy tabletsDaily tabletFoundayoDaily tablet
Average weight lost in trials20.9%14.9%16.6%12.4%
Trial behind the figureSURMOUNT-1STEP 1OASIS 4ATTAIN-1
Trial length72 weeks68 weeks64 weeks72 week
Active ingredientTirzepatideSemaglutideOral semaglutideOrforglipron
How you take itWeekly penWeekly penDaily tabletDaily tablet
How oftenOnce a week, same dayOnce a week, same dayOnce a day, before foodOnce a day, any time
Strengths available6646
StorageFridge until first useFridge until first useNo fridgeNo fridge
NeedlesYesYesNoneNone
From, a month£195£139£125£120
Tends to suitYou want the largest average result and are happy with a weekly injection.You want the option with the longest track record behind it.You want the results of semaglutide without an injection.You want the simplest possible daily routine and the lowest starting price.

Trial figures come from separate studies and are not head-to-head comparisons. Averages, not promises.

Choose a treatment to project

Your projection

See what 20.9% weight loss looks like for you

Put in your details to see a personalised trajectory over 72 weeks, based on Mounjaro trial outcomes.

Enter your details

Included either way

The care does not change with the medicine

Clinician review

Before anything is issued

UK pharmacy

GPhC registered, MHRA regulated

Tracked delivery

Next weekday, tracked

WhatsApp support

Seven days a week

Progress check-ins

As your dose steps up

Cancel any time

No lock-in, no consultation fee

Questions

Asked before choosing

In head-to-head terms, tirzepatide (Mounjaro) has produced the largest average weight loss of the licensed options in the UK: around 20.9% of body weight over 72 weeks in SURMOUNT-1, compared with about 14.9% for semaglutide 2.4mg (Wegovy) over 68 weeks in STEP 1. Trials are not directly comparable, and the best treatment for an individual is the one they tolerate and can keep taking, which is why a prescriber weighs medical history and side-effect risk rather than the headline figure alone.

There is no tablet form of tirzepatide licensed in the UK. Two oral GLP-1 options are available instead: oral semaglutide taken once a day, and orforglipron (Foundayo), also once a day. Average weight loss in their trials is lower than tirzepatide, so a tablet is usually chosen by people who want to avoid injections rather than by people chasing the largest possible result.

Wegovy tablets contain semaglutide, a peptide, so absorption is sensitive to food and drink: the tablet is taken on an empty stomach with a small sip of water, and food is delayed afterwards. Foundayo contains orforglipron, a small molecule, so it can be taken at any time of day with or without food. In their respective trials oral semaglutide 25mg produced about 16.6% average weight loss over 64 weeks and orforglipron about 12.4%.

Not quite, on the trial figures available. Weekly injections have produced the largest average reductions in body weight, with daily tablets somewhat behind. The gap matters less than adherence: a treatment taken consistently for a year outperforms a stronger one abandoned in month two, which is why the practical fit — needles, fridge space, routine — is part of the clinical decision.

Yes, switching is common and is done under prescriber supervision. Reasons include side effects, supply, cost, or wanting to move off injections. A switch usually restarts at a low dose of the new medicine rather than matching the old dose, because tolerance does not transfer between molecules, and the escalation is then stepped up again over several weeks.

Private prices typically run from around £120 to £375 a month depending on the medicine and the strength, with the lowest starting doses costing least and maintenance strengths costing most. A reputable service includes the prescriber review, the medicine, delivery and ongoing support in that figure, with no separate consultation fee.

In UK private practice, treatment is generally considered at a BMI of 30 or above, or 27 or above alongside a weight-related condition such as high blood pressure, prediabetes, obstructive sleep apnoea or high cholesterol. Lower thresholds apply for people of South Asian, Chinese, Black African or African-Caribbean family background. Eligibility is confirmed by a prescriber reviewing full medical history, not by a calculator alone.

Appetite signalling returns to its previous state, and without a plan some weight is usually regained: the SURMOUNT-4 and STEP 4 withdrawal trials both showed this clearly. Ending treatment responsibly means tapering rather than stopping abruptly, with nutrition, resistance exercise and follow-up in place before the last dose so the change has somewhere to hold.

Written by · 18 August 2026

Ali Salih, MPharm

Prescribing Pharmacist, Weight Loss Specialist
GPhC 2212755

Medically reviewed by · 28 August 2026

Mr M T

Clinical Pharmacist, Weight Loss Specialist Prescriber
GPhC 2233158

★★★★★

5.0 / 5

from verified patient reviews

Begin your clinical assessment today

Prescription, clinician review and next-day weekday delivery to your door.

✓ Prescribed only after a clinician review

Quick self-check

Find out if a weight loss pen is right for you

Three quick questions. Takes under a minute.

Question 1 of 3

Your answers are confidential and reviewed by UK-registered clinicians.

Online Treatments

WEIGHT LOSS

Wegovy

Established pen

Lose 14.9% body weight
Mounjaro

Advanced pen

Lose 20.9% body weight
Wegovy Tablets

Daily oral — needle-free

Lose 13.6% body weight
Foundayo

Daily tablet — no timing rules

Lose 12.4% body weight
London Clinics

LONDON LOCATIONS

10 Harley Street

Marylebone · W1G · £250

Flagship
The Charterhouse Clinic

Marylebone · W1H · £150

♢   UK-registered clinicians · Next-day weekday delivery